Susan Vallow, VP, Patient Centered Outcomes Strategy, MedAvante-ProPhase, is an experienced outcomes researcher with a specialty in the strategy, development and implementation of PROs. Sue previously was Senior Director & Head, Patient Focused Outcomes at GSK, where she managed the team that led patient outcomes strategies and electronic patient reported outcomes (ePRO) implementation in clinical trials. She served as the Critical-Path Institute’s PRO Consortium ePRO subcommittee Co-Chair, ePRO Consortium Research Committee Co-Lead, a member of PhRMA’s PRO working group, and a leader in the TransCelerate Patient Experience & Technology initiative. She has co-authored more than 20 peer-reviewed papers and 70 research posters/presentations

Paul O’Donohoe is Senior Director, eCOA Product and Science at Medidata Solutions, a clinical software platform provider. He is responsible for providing strategic oversight of the development of Medidata's electronic clinical outcome assessment technologies, and supporting internal teams and partners around the implementation of industry, regulatory and scientific best practices in clinical trials using mobile health technologies. He is passionate about developing the field of eCOA and mobile health through research and active involvement in industry consortia, and is currently the Industry Vice-Director of the C-Path ePRO Consortium.

Patricia (Trish) Shepherd Delong has worked in the PRO and eCOA fields for more than ten years in both contract research and pharmaceutical organizations. She currently holds the role of PRO Process expert within the PRO team at Janssen. In this role Trish represents the PRO functional area in various internal projects and initiatives relating to process improvements. Trish has extensive process improvement experience and is certified Six Sigma Lean Green Belt. Across various roles she has developed tools and processes to help business partners work more efficiently. Trish holds a Bachelor of Science in Biology and a Master of Science in Clinical Research.